Delivery Order SPE2DR25D1201-SPE2DR26FAJNE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin products, with a ceiling value of $2,710.33. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is expected to be completed by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,548.76. This is a firm fixed price delivery order with an ultimate completion date of October 16, 2025, executed without a set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $18,586.11 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin products with a ceiling value of $4,935.21. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for ultimate completion on September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $16,490.54 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Humulin R 500 unit/mL KwikPen insulin in 3 mL configurations. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,097.52. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a contract value of $6,473.57 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $20,724.74. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical procurement through DLA's medical supply chain to support federal...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJNEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin products, valued at $2,249.10. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The order is set for ultimate completion by October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen consistently fulfills federal medical procurement requirements through the DLA's supply chain, supporting critical healthcare operations for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/21/25 |